Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-001576
Accepted
2025-05-15 00:15:05
Documents
1
Effectiveness Date
2025-05-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 607
  Complete submission text file 9999999995-25-001576.txt   1768
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-267578 | Film No.: 25948276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)